Publications by authors named "Azadeh Razmandi"

Claim this Profile
T
Treatment experience with encorafenib plus binimetinib for BRAF V600-mutant metastatic melanoma: management insights for clinical practice.
Kourtney Augustyn, Jocelyn Joseph, Anisha B Patel, Azadeh Razmandi, Amatul Noor Ali

Melanoma Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular Toxicity Profile of Targeted Cancer Therapy (TCT) at a US Tertiary Cancer Center.
Moe Ameri, Nagham Al Zubidi, Azadeh Razmandi, Andrew Whyte, Aung Naing

Cureus· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Ocular Toxicity in Patients Receiving Belantamab Mafodotin.
Rebecca Lu, Ashley Morphey, Felicia Diaz, Jessica Chen, Azadeh Razmandi

J Adv Pract Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highlights on Ocular Toxicity of Immune Checkpoint Inhibitors at a US Tertiary Cancer Center.
Anam A Mazharuddin, Andrew T Whyte, Dan S Gombos, Nimisha Patel, Azadeh Razmandi

J Immunother Precis Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinguishing and quantification of the human visual pathways using high-spatial-resolution diffusion tensor tractography.
Arash Kamali, Khader M Hasan, Pavani Adapa, Azadeh Razmandi, Zafer Keser

Magn Reson Imaging· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis